Zhang J, Ren C, Qin Z, Zhu L, Jin Z, Yan Y
Front Med (Lausanne). 2024; 11:1445288.
PMID: 39450106
PMC: 11499175.
DOI: 10.3389/fmed.2024.1445288.
Morelli M, Madonna S, Albanesi C
Front Immunol. 2024; 15:1393799.
PMID: 38975347
PMC: 11224294.
DOI: 10.3389/fimmu.2024.1393799.
Akazawa H, Nozaki Y, Yamazawa H, Ishimura K, Ashida C, Okada A
Front Med (Lausanne). 2023; 10:1293132.
PMID: 37964882
PMC: 10641785.
DOI: 10.3389/fmed.2023.1293132.
Lee B, Moon S
Int J Mol Sci. 2023; 24(14).
PMID: 37511421
PMC: 10381020.
DOI: 10.3390/ijms241411662.
Chen S, Liao P, Xi L, Yang Y, Wu W, Islam M
Rheumatol Immunol Res. 2023; 3(4):190-197.
PMID: 36879838
PMC: 9984933.
DOI: 10.2478/rir-2022-0034.
Immunological risk factors for nonalcoholic fatty liver disease in patients with psoriatic arthritis: New predictive nomograms and natural killer cells.
Li B, Su R, Yan H, Liu J, Gao C, Li X
Front Immunol. 2022; 13:907729.
PMID: 35935983
PMC: 9355654.
DOI: 10.3389/fimmu.2022.907729.
Roles of Infection in Psoriasis.
Zhou S, Yao Z
Int J Mol Sci. 2022; 23(13).
PMID: 35805960
PMC: 9266590.
DOI: 10.3390/ijms23136955.
Coptisine Alleviates Imiquimod-Induced Psoriasis-like Skin Lesions and Anxiety-like Behavior in Mice.
Nguyen L, Choi M, Shin H, Yang I
Molecules. 2022; 27(4).
PMID: 35209199
PMC: 8878104.
DOI: 10.3390/molecules27041412.
Orchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action.
Noor A, Azlan M, Mohd Redzwan N
Biomedicines. 2022; 10(2).
PMID: 35203707
PMC: 8962336.
DOI: 10.3390/biomedicines10020498.
Promising Strategies in Plant-Derived Treatments of Psoriasis-Update of In Vitro, In Vivo, and Clinical Trials Studies.
Nowak-Perlak M, Szpadel K, Jablonska I, Pizon M, Wozniak M
Molecules. 2022; 27(3).
PMID: 35163855
PMC: 8839811.
DOI: 10.3390/molecules27030591.
Current Concepts of Psoriasis Immunopathogenesis.
Vicic M, Kastelan M, Brajac I, Sotosek V, Massari L
Int J Mol Sci. 2021; 22(21).
PMID: 34769005
PMC: 8584028.
DOI: 10.3390/ijms222111574.
The Role of Co-Signaling Molecules in Psoriasis and Their Implications for Targeted Treatment.
Liu S, Xu J, Wu J
Front Pharmacol. 2021; 12:717042.
PMID: 34354596
PMC: 8329336.
DOI: 10.3389/fphar.2021.717042.
Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19.
Yendo T, Sato M, Castelo Branco A, Pietrobon A, Emidio Teixeira F, Ramos Y
Vaccines (Basel). 2021; 9(5).
PMID: 34068473
PMC: 8151299.
DOI: 10.3390/vaccines9050478.
Centennial History of Yonsei University Dermatology in Korea: 1917 to 2017.
Kim J, Kim T, Lee S, Lee M, Kim J, Lee S
Ann Dermatol. 2021; 30(5):513-521.
PMID: 33911472
PMC: 7992467.
DOI: 10.5021/ad.2018.30.5.513.
Interleukin 22 and 6 serum concentrations decrease under long-term biologic therapy in psoriasis.
Olejniczak-Staruch I, Narbutt J, Bednarski I, Wozniacka A, Sieniawska J, Kraska-Gacka M
Postepy Dermatol Alergol. 2020; 37(5):705-711.
PMID: 33240010
PMC: 7675072.
DOI: 10.5114/ada.2020.100481.
Psoriatic arthritis under the influence of IFNγ.
Dai H, Adamopoulos I
Clin Immunol. 2020; 218:108513.
PMID: 32574710
PMC: 7595649.
DOI: 10.1016/j.clim.2020.108513.
The Role of Calcium-Calcineurin-NFAT Signaling Pathway in Health and Autoimmune Diseases.
Park Y, Yoo S, Kim M, Kim W
Front Immunol. 2020; 11:195.
PMID: 32210952
PMC: 7075805.
DOI: 10.3389/fimmu.2020.00195.
Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances.
Shao S, Wang G, Maverakis E, Gudjonsson J
Drugs. 2020; 80(6):525-534.
PMID: 32180204
PMC: 7167352.
DOI: 10.1007/s40265-020-01283-2.
Biological depletion of neutrophils attenuates pro-inflammatory markers and the development of the psoriatic phenotype in a murine model of psoriasis.
Han G, Havnaer A, Lee H, Carmichael D, Martinez L
Clin Immunol. 2019; 210:108294.
PMID: 31678366
PMC: 8043213.
DOI: 10.1016/j.clim.2019.108294.
Effect of white mange mixture in a murine model of psoriasis.
Guo J, Liu J
Exp Ther Med. 2019; 18(2):881-887.
PMID: 31384318
PMC: 6639981.
DOI: 10.3892/etm.2019.7641.
